Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 4,033–4,040 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Theravance Biopharma Inc. Telavancin Bacteremia Phase 3 Trial Discontinued Intravenous Antibiotic
Theravance Biopharma Inc. Ampreloxetine - (REDWOOD 0170) Neurogenic orthostatic hypotension (nOH) Phase 3 Data Released Oral Neurology
Theravance Biopharma Inc. YUPELRI (revefenacin) - (China trial) Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Data Released Inhalation Respiratory
Theravance Biopharma Inc. YUPELRI (revefenacin) - (PIFR-2) Chronic obstructive pulmonary disease (COPD) Phase 3 Data Released Inhalation Respiratory
Theravance Biopharma Inc. Izencitinib Ulcerative Colitis Phase 2b Trial Discontinued Oral Gastroenterology
Theravance Biopharma Inc. Velusetrag (TD-5108) Gastroparesis Phase 2b Trial Discontinued Oral Gastroenterology
Theravance Biopharma Inc. Nezulcitinib Acute Lung Injury (ALI) caused by COVID-19 Phase 2 Trial Discontinued Inhalation COVID-19
Theravance Biopharma Inc. TD-8236 Asthma Phase 2 Trial Discontinued Inhalation Respiratory